174 related articles for article (PubMed ID: 11271219)
1. Antilymphocyte globulins versus OKT3 as prophylactic treatment in highly sensitized renal transplant recipients.
Vela C; Cristol JP; Chong G; Okamba A; Lorho R; Mion C; Mourad G
Transpl Int; 1994; 7 Suppl 1():S259-62. PubMed ID: 11271219
[TBL] [Abstract][Full Text] [Related]
2. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
3. Antilymphocyte globulin versus OKT3 induction therapy in cadaveric kidney transplantation: a prospective randomized study.
Grino JM; Castelao AM; Serón D; Gonzalez C; Galceran JM; Gil-Vernet S; Andrés E; Mestre M; Torras J; Alsina J
Am J Kidney Dis; 1992 Dec; 20(6):603-10. PubMed ID: 1462990
[TBL] [Abstract][Full Text] [Related]
4. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Kitabayashi K; Munn SR; Sterioff S
Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
[No Abstract] [Full Text] [Related]
5. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
[TBL] [Abstract][Full Text] [Related]
6. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
Mariat C; Alamartine E; Diab N; de Filippis JP; Laurent B; Berthoux F
Transpl Int; 1998; 11(3):231-6. PubMed ID: 9638854
[TBL] [Abstract][Full Text] [Related]
7. Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression.
Elias TJ; Bannister KM; Clarkson AR; Russ GR; Mathew TH; Barratt LJ; Faull RJ
Clin Transplant; 2000 Apr; 14(2):157-61. PubMed ID: 10770422
[TBL] [Abstract][Full Text] [Related]
8. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
Hanto DW; Jendrisak MD; So SK; McCullough CS; Rush TM; Michalski SM; Phelan D; Mohanakumar T
Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
[TBL] [Abstract][Full Text] [Related]
9. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
[TBL] [Abstract][Full Text] [Related]
10. The risk of infection following OKT3 and antilymphocyte globulin treatment for renal transplant rejection: results of a single center prospectively randomized trial.
Hesse UJ; Wienand P; Baldamus C; Pollok M; Pichlmaier H
Transpl Int; 1992; 5 Suppl 1():S440-3. PubMed ID: 14621840
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive therapy in renal transplantation].
Nakamura H
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1359-84. PubMed ID: 8411796
[TBL] [Abstract][Full Text] [Related]
12. Influence of immunosuppressive therapy on infectious complications in renal transplant recipients.
Klauser R; Zlabinger GJ; Traindl O; Franz M; Watschinger B; Pohanka E; Kudlacek S; Kovarik J
Transplant Proc; 1992 Feb; 24(1):292-4. PubMed ID: 1539284
[No Abstract] [Full Text] [Related]
13. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
[TBL] [Abstract][Full Text] [Related]
14. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy.
Kehinde EO; Feehally J; Scriven SD; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735
[No Abstract] [Full Text] [Related]
15. Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study.
Balk AH; Meeter K; Simoons ML; Brouwer RM; Zondervan PE; Mochtar B; Bos E; Weimar W
Transpl Int; 1992; 5 Suppl 1():S476-9. PubMed ID: 14621851
[TBL] [Abstract][Full Text] [Related]
16. Preventive OKT3 treatment with cyclosporine (Sandimmun) for second kidney transplantation.
Perner F; Alföldy F; Járay J; Hidvégi M; Hemangshu P
Transpl Int; 1994; 7 Suppl 1():S255-8. PubMed ID: 11271218
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts.
Menkis AH; Powell AM; Novick RJ; McKenzie FN; Kostuk WJ; Pflugfelder PW; Brown JE; Rochon J; Chow LH; Stiller C
J Heart Lung Transplant; 1992; 11(3 Pt 1):569-76. PubMed ID: 1610866
[TBL] [Abstract][Full Text] [Related]
18. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
19. OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation.
D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Maki DG; Belzer FO
Transplantation; 1989 Feb; 47(2):297-300. PubMed ID: 2493176
[TBL] [Abstract][Full Text] [Related]
20. Low-dose OKT3 induction therapy following renal transplantation: a controlled study.
Parlevliet KJ; ten Berge RJ; Raasveld MH; Surachno J; Wilmink JM; Schellekens PT
Nephrol Dial Transplant; 1994; 9(6):698-703. PubMed ID: 7970099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
